These are reasons why I bought ACR. Please be aware that I just share some info, not recommend to buy or sell, please dyor and take your own risk.
1. cash at the end of 2017, $32m, current MC is [email protected].
2. ACR transformed to make generic products since 2015, now it's on track to develop more generic products and apply FDA.
3. one director bought $9,999 on the market @0.165, not big money, but a small good signal.
4. Samuel Terry Asset Management pty ltd purchased from 12.2017 to 4.2018, counts 6.15%
5. I also checked the recent Broker Data, Baillieu Holst Pershing are the top two institutions, who hold more than retailers. Roughly guess, their price may be around 0.155-0.16
6. future events may attract fresh blood to invest into ACR
7. TA perspective, the sp is in the correction stage, it just retraced to the fib 50% level @0.19, 0.19 was also a breakout point, wish it can hold.
Add to My Watchlist
What is My Watchlist?
